Produced by:
INTERPHEX Webinar Series
Pharmaceutical Technology and BioPharm International present the Editor’s Series – Live Webcast
Event Overview
The global coronavirus pandemic has tested the abilities of bio/pharmaceutical companies to develop new therapies and maintain—or even accelerate—production of existing drugs. Travel bans, restricted access to facilities, and supply chain disruptions are just a few of the challenges facing drug companies, that must provide essential medicines under adverse conditions while protecting their employees and adhering to good manufacturing practices.
In the initial weeks of the coronavirus pandemic, bio/pharma companies, contract service providers, and regulatory authorities have taken measures to ensure continued operations during the present emergency. While addressing the challenges of today, the bio/pharma industry also needs to look ahead to what may be new operating conditions for the coming months or years.
Join the editors of Pharmaceutical Technology and BioPharm International for interviews and discussions with experts about business continuity practices, regulatory compliance, and supply chain management under current—or future—emergency conditions.
Topics to be discussed include:
Business continuity best practices
Employee and facility safety
Regulatory compliance
Addressing deviations
Testing guidance for new and existing drugs
Supplier oversight
Supply chain challenges
Data security, data integrity, and remote data access and collaboration
July Webcasts
Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies
Tuesday, July 28, 2020, 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST
Presenters:
Alan Moore
Chief Strategy Officer
The Discovery Labs
Christopher Murphy
Vice President and General Manager, Viral Vector Services
Thermo Fisher Scientific, Pharma Services Group
Thomas VanCott, PhD
Global Head of Product Development, Cell & Gene Therapy
Catalent Cell & Gene Therapy
Moderators:
Rita Peters, Editorial Director, BioPharm International and Pharmaceutical Technology
Feliza Mirasol, Science Editor, BioPharm International and Pharmaceutical Technology
Editors’ Series: Cell and Gene Therapies: Laying the Foundation for a New Supply Chain
July 29, 2020, 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST
Presenters:
Alberto Santagostino
Senior Vice President and Head of Cell and Gene Therapies
Lonza Pharma and Biotech
Amy DuRoss
Co-Founder and CEO
Vineti
Mark Sawicki
Chief Commercial Officer
Cryoport
Moderator:
Agnes Shanley, Senior Editor, BioPharm International and Pharmaceutical Technology
May
Editors’ Series: Strategies for Designing Adaptable, Resilient Bio/Pharma Facilities
Tuesday, May 26, 2020 2pm EDT | 1pm CDT | 11am PDT
Presenters:
Jason S. Collins, AIA, Director, Process Architecture, IPS
Curt Firestine, Mechanical Engineer, CRB
Moderators:
Rita Peters, Editorial Director, Pharmaceutical Technology
Jennifer Markarian, Manufacturing Editor, Pharmaceutical Technology
April
Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times
Tuesday, April 28, 2020, 11 am EDT | 10 am CDT | 8 am PDT
Hear from the editors of Pharmaceutical Technology and BioPharm International connect with experts about business continuity practices, regulatory compliance, and supply chain management under current—or future—emergency conditions.